Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Lexmark International Inc

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Lexmark International Inc. from 1994 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Goldner, Noah
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Computer and Office Equipment, Computer peripherals industry, Company sales and earnings, Lexmark International Group Inc., Company earnings/profit

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Saks, Inc

Article Abstract:

The shares of Saks, Inc. have little capital gains potential for the 2010-2012 timeframe. The New York, New York-based company is a leading retailer of moderate to better brand-name fashion apparel, shoes, accessories, and cosmetics.

Author: Spencer, Matthew E.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Department Stores, Evaluation, Stocks, Stock prices, Saks Inc., SKS, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Securities, Company securities
Similar abstracts:
  • Abstracts: Dentsply Internt'l. Dentsply International Inc
  • Abstracts: Interface, Inc. Interface Inc
  • Abstracts: Unifi, Inc. Paxar Corporation
  • Abstracts: AutoZone, Inc.. AutoZone Inc. Auto parts industry
  • Abstracts: CarMax, Inc. CarMax Group
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.